Viewing Study NCT06381817



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06381817
Status: RECRUITING
Last Update Posted: 2024-04-26
First Post: 2024-04-19

Brief Title: Haplo-cord HCT vs Haplo-HCT for T-ALL Patients
Sponsor: The First Affiliated Hospital of Soochow University
Organization: The First Affiliated Hospital of Soochow University

Study Overview

Official Title: Haploidentical Hematopoietic Cell Transplantation Combined With an Unrelated Cord Blood Unit for Acute T Cell Lymphoblastic Leukemia Compared to Haploidentical Hematopoietic Cell Transplantation a Multicenter Randomized Open-label Trial
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if haploidentical hematopoietic cell transplantation combined with an unrelated cord blood unit haplo-cord HCT works to treat acute T cell lymphoblastic leukemia T-ALL It will also learn about the safety of the transplantation The main questions it aims to answer are

Dose co-infusion of cord blood in haploidentical hematopoietic cell transplantation haplo-HCT lower the rate of relapse What medical problems do participants have when having haplo-cord HCT Researchers will compare haplo-cord HCT to haplo-HCT to see if haplo-cord HCT works to treat T-ALL

Participants will be infused an unrelated cord blood unit at the same day of haploidentical graft infusion
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None